Five years of experience and observation with therapy of maintenance with very low dose thalidomide after auto-SCT in multiple myeloma

被引：0
|
作者：
Pezzullo, L. [1 ]
Rocco, S. [1 ]
Bene, L. [1 ]
Ferrara, M. G. [1 ]
Finizio, O. [1 ]
Nunziata, G. [1 ]
Martorelli, C. [1 ]
Mettivier, L. [1 ]
Buonanno, M. T. [1 ]
Mettivier, V [1 ]
机构：
[1] Cardarelli Hosp, Hematol Div A, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：146 / 147
页数：2
相关论文
共 50 条
  • [1] Five years of experience and observation with therapy of maintenance with very low-dose thalidomide after auto-SCT in multiple myeloma
    Pezzullo, L.
    Rocco, S.
    Finizio, O.
    Ferrara, M. G.
    Bene, L.
    Mettivier, L.
    Nunziata, G.
    De Rosa, C.
    Mettivier, V.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S441 - S442
  • [2] Maintenance with very low dose thalidomide after auto-SCT in multiple myeloma: low toxicity and improved outcome
    Mettivier, V
    Pezzullo, L
    Rocco, S
    Bene, L
    Finizio, O
    Nunziata, G
    De Rosa, C
    Mettivier, L
    BONE MARROW TRANSPLANTATION, 2006, 37 : S138 - S138
  • [3] Outcomes after auto-SCT in African Americans with multiple myeloma
    Y Khaled
    M H Abidi
    N Janakiraman
    K Kato
    J E Levine
    P Reddy
    M Medina
    E Peres
    A Hanbali
    S Mineishi
    Bone Marrow Transplantation, 2009, 43 : 845 - 851
  • [4] Outcomes after auto-SCT in African Americans with multiple myeloma
    Khaled, Y.
    Abidi, M. H.
    Janakiraman, N.
    Kato, K.
    Levine, J. E.
    Reddy, P.
    Medina, M.
    Peres, E.
    Hanbali, A.
    Mineishi, S.
    BONE MARROW TRANSPLANTATION, 2009, 43 (11) : 845 - 851
  • [5] Impact of early relapse after auto-SCT for multiple myeloma
    Kumar, S.
    Mahmood, S. T.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Buadi, F. K.
    Dingli, D.
    Rajkumar, S. V.
    Litzow, M. R.
    Gertz, M. A.
    BONE MARROW TRANSPLANTATION, 2008, 42 (06) : 413 - 420
  • [6] Impact of early relapse after auto-SCT for multiple myeloma
    S Kumar
    S T Mahmood
    M Q Lacy
    A Dispenzieri
    S R Hayman
    F K Buadi
    D Dingli
    S V Rajkumar
    M R Litzow
    M A Gertz
    Bone Marrow Transplantation, 2008, 42 : 413 - 420
  • [7] Six Years of Experience and Outcome with Maintenance Therapy with Very Low-Dose Thalidomide After AU
    Mettivier, V.
    Pezzullo, L.
    Rocco, S.
    Finizio, O.
    Bene, L.
    Nunziata, G.
    Mettivier, L.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S91 - S91
  • [8] Low dose thalidomide as maintenance in multiple myeloma
    ElSorady, M.
    ElGhandour, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 355 - 355
  • [9] Low dose thalidomide as maintenance in multiple myeloma
    El Sorady, M.
    Elghandour, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 481 - 481
  • [10] Retraction Note: First-line thalidomide–dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma
    A Abdelkefi
    L Torjman
    N Ben Romdhane
    S Ladeb
    H El Omri
    T Ben Othman
    M Elloumi
    H Bellaj
    A Lakhal
    R Jeddi
    L Aissaouï
    A Saad
    M Hsaïri
    K Boukef
    K Dellagi
    A Ben Abdeladhim
    Bone Marrow Transplantation, 2009, 43 : 893 - 893
12345